Citigroup reaffirmed their buy rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research note released on Thursday, Benzinga reports. Citigroup currently has a $63.00 price objective on the medical equipment provider’s stock. A number of other analysts have also weighed in on BSX. 22nd Century Group restated an initiates rating on […]
Boston Scientific (NYSE:BSX – Free Report) had its price objective lifted by Robert W. Baird from $60.00 to $63.00 in a research note released on Thursday morning, MarketBeat.com reports. The brokerage currently has an outperform rating on the medical equipment provider’s stock. Several other equities analysts also recently issued reports on the company. Royal Bank […]
Boston Scientific (NYSE:BSX – Get Free Report) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $1.96-2.00 for the period, compared to the consensus earnings per share estimate of $2.00. Boston Scientific Stock Performance BSX stock opened at $54.10 on Thursday. The company has a […]
Whitaker Myers Wealth Managers LTD. bought a new stake in Boston Scientific Co. (NYSE:BSX – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,779 shares of the medical equipment provider’s stock, valued at approximately $204,000. A number of other […]
Bouvel Investment Partners LLC boosted its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 2.9% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 43,175 shares of the medical equipment provider’s stock after acquiring an additional 1,219 shares during the period. Bouvel Investment Partners LLC’s holdings in Boston Scientific were worth $2,335,000 at […]